A Test You Can Trust

Genetic Testing - Hereditary Cancer

Comprehensive analysis of 174 genes linked to 17 cardiovascular conditions

BE PROACTIVE – Know your genetic predisposition to various types of cardiac conditions (heart diseases) and TAKE ACTION BASED ON YOUR RESULTS

Lifestyle and diet aren’t the only factors of the health of your heart. Genetic play a major role in it. Take action today– and get a better understanding of your heart health. Genetic testing identifies changes in your genes that could increase your risk for developing a a serious, inherited form of heart disease, even if you generally healthy and without a personal or family history.

We are bridging science to clinical practice by implementing cutting edge technology to evaluate your hereditary cardiac conditions risk. We provide DNA sequencing for targeted panels, allowing us to focus on specific areas of interest at a reduced price and faster delivery time.

Our laboratory’s technology can accommodate samples collected by medical grade foam tipped buccal swab, making it viable alternative to a trip to the phlebotomist and reducing the impact of blood-drawing on patients’ health.

Our Cardio Sequencing Panel focuses on identifying 17 inherited cardiac conditions

Our panel targets 174 genes with known associations to 17 inherited cardiac conditions including cardiomyopathy, arrhythmia, hypercholesterolemia, hypertriglyceridemia, aortopathy and more. This assay is performed using genomic DNA isolated from blood collected via capillary puncture or a swab.

The test is intended for predictive genetic testing to determine the chances that a healthy individual with or without a family history of a cardiac condition might develop heart disease.

Its is also performed as a pre-symptomatic genetic testing in order to determine whether an individual with a family history of a cardiac disease, but no current symptoms, has the gene alterations associated with the heart disease. It is also intended for post-symptomatic genetic testing to identify the potential underlying cause of an existing cardiac disease.

ABCC9, ABCG5, ABCG8, ACTA1, ACTA2, ACTC1, ACTN2, AKAP9, ALMS1, ANK2,ANKRD1, APOA4, APOA5, APOB, APOC2, APOE, BAG3, BRAF, CACNA1C, CACNA2D1, CACNB2, CALM1, CALR3, CASQ2, CAV3, CBL, CBS, CETP, COL3A1, COL5A1, COL5A2, COX15, CREB3L3, CRELD1, CRYAB, CSRP3, CTF1, DES, DMD, DNAJC19, DOLK, DPP6, DSC2, DSG2, DSP, DTNA, EFEMP2, ELN, EMD, EYA4, FBN1, FBN2, FHL1, FHL2, FKRP, FKTN, FXN, GAA, GATAD1, GCKR, GJA5, GLA, GPD1L, GPIHBP1, HADHA, HCN4, HFE, HRAS, HSPB8, ILK, JAG1, JPH2, JUP, KCNA5, KCND3, KCNE1, KCNE2, KCNE3, KCNH2, KCNJ2, KCNJ5, KCNJ8, KCNQ1, KLF10, KRAS, LAMA2, LAMA4, LAMP2, LDB3, LDLR, LDLRAP1, LMF1, LMNA, LPL, LTBP2, MAP2K1, MAP2K2, MIB1, MURC (CAVIN4), MYBPC3, MYH11, MYH6, MYH7, MYL2, MYL3, MYLK, MYLK2, MYO6, MYOZ2m MYPN, NEXN, NKX2-5, NODAL, NOTCH1, NPPA, NRAS, PCSK9, PDLIM3, PKP2, PLN, PRDM16, PRKAG2, PRKAR1A, PTPN11, RAF1, RANGRF, RBM20, RYR1, RYR2, SALL4, SCN1B, SCN2B, SCN3B, SCN4B, SCN5A, SCO2, SDHA, SEPN1, SGCB, SGCD, SGCG, SHOC2, SLC25A4, SLC2A10, SMAD3, SMAD4, SNTA1, SOS1, SREBF2, TAZ, TBX20, TBX3, TBX5, TCAP, TGFB2, TGFB3, TGFBR1, TGFBR2, TMEM43, TMPO, TNNC1, TNNI3, TNNT2, TPM1, TRDN, TRIM63, TRPM4, TTN, TTR, TXNRD2, VCL, ZBTB17, ZHX3, ZIC3
Aortic Valve Disease
Marfan Syndrome
Loeys-Dietz Syndrome
Short QT Syndrome
Catecholaminergic Polymorphic
Ventricular Tachycardia (CPVT)
Familial Hypercholesterolemia
Restrictive Cardiomyopathy
Non-Compaction Cardiomyopathy
Noonan Syndrome
Arrhythmogenic Right Ventricular
Cardiomyopathy (ARVC)
Brugada Syndrome
Structural Heart Disease
Long QT Syndrome
Familial Aortic Aneurysm
Familial Atrial Fibrillation
Hypertrophic Cardiomyopathy
Dilated Cardiomyopathy

Why to get tested?

ADVANCED KNOWLEDGE

The advance knowledge that you might develop heart disease or you have a 50% increased risk of suffering a heart attack and the decisions you face when you acquire this knowledge.
Mutations in genes can affect the way the heart cells communicate, the strength of the heart muscle, and affect the heart rhythm condition resulting in fast, chaotic heartbeats. Identifying these genetic factors now plays an important role in the disease prognosis, therapy and therefore outcome.

MEDICATION RESPONSE

Up to 40% of people have a gene variants that prevents their liver from activating medication, putting them at increased risk for a clot-caused heart attack. Our Pharmacogenetic Testing allows us to assess the likelihood that an individual will have a normal, reduced, or enhanced response to certain medications. This is very important because it dictates how a person responds to a treatment prior to actually receiving the treatment based on their genetics, improving efficacy and reducing adverse effects.

We strongly recommend that you seek genetic counseling to understand the limitations and possible consequences of this test.

All tests are performed in Ayass BioScience, LLC. Ayass BioScience, LLC (DBA Ayass Lung Clinic, PLLC) is a CLIA certified laboratory. If you have any questions about COVID-19 Testing, Genetic Testing, Clinical Testing, Pharmacogenetic Testing or Research at Ayass BioScience, LLC, please call today at 972-668-6005 or fill out our contact form on the bottom of this page. We will answer any question you might have.